08
October 2024
Past Event
Do Drug Patents Cause High Drug Prices?

Event will air on this page.

 

Inquiries: msnow@hudson.org

Do Drug Patents Cause High Drug Prices?

Past Event
Online Only
October 08, 2024
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
Caption
Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024. (Spencer Platt via Getty Images)
08
October 2024
Past Event

Event will air on this page.

 

Inquiries: msnow@hudson.org

Speakers:
Adam Mossoff
Adam Mossoff

Chair, Forum for Intellectual Property and Senior Fellow

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law
Erika Lietzan

William H. Pittman Professor of Law and Timothy J. Heinsz Professor of Law, University of Missouri School of Law

Vice President and Global Head of Intellectual Property Affairs, Novartis
Corey A. Salsberg

Vice President and Global Head of Intellectual Property Affairs, Novartis

Moderator:
hartline
Devlin Hartline

Senior Fellow

For the past decade, policy activists have argued that drug innovators artificially extend the length of their exclusive patent protections on their drugs solely to keep drug prices high. One activist organization, the Initiative for Medicines, Access, and Knowledge (I-MAK), alleges that as many as 50 patents currently protect drugs from generic competition. 

But are I-MAK’s patent numbers correct? A 2022 Hudson policy memo, “How Unreliable Data Has Infected the Policy Debate Over Drug Patents,”detailed how I-MAK’s patent numbers contradict the number of drug patents listed in the Orange Book, the Food and Drug Administration’s official database of drug patents. Academic scholars have also done rigorous empirical studies, and the United States Patent and Trademark Office (USPTO) released its own empirical study in June 2024. Neither the USPTO nor the academic studies could replicate or confirm activist organizations’ patent numbers. Yet I-MAK’s claims continue to drive legislative proposals and agency actions.

Join Hudson for an expert discussion on the state of play concerning the empirical evidence on the connection between drug patents and drug prices and whether officials are engaging in evidence-based policymaking on this pressing concern.

Related Events
24
August 2026
In-Person Event | Hudson Institute
Twenty Times I Almost Died: Lessons on Life and War
Featured Speakers:
John Spencer
Rebeccah L. Heinrichs
A US soldier pulls security at the al-Faw intermediate school in the Sadr City area of Baghdad on August 15, 2008. (US Army)
24
August 2026
In-Person Event | Hudson Institute
Twenty Times I Almost Died: Lessons on Life and War

Please join Hudson Institute for a fireside chat with Senior Fellow and Keystone Defense Initiative Director Rebeccah Heinrichs and John Spencer, chair of Urban Warfare Studies at the Modern War Institute at West Point and co-director of the Urban Warfare Project. 

A US soldier pulls security at the al-Faw intermediate school in the Sadr City area of Baghdad on August 15, 2008. (US Army)
Featured Speakers:
John Spencer
Rebeccah L. Heinrichs
28
August 2026
In-Person Event | Invite Only
Nigeria’s Crisis: Islamist Terrorists, Violent Nomadic Herders, “Bandit” Gangs, and the US Foreign Policy Response
Featured Speakers:
Matthew Boyse
The Rev. Fr. Remigius Ihyula
Joshua Meservey
Ambassador Tibor Nagy
Emmanuel Ogebe
Judd Saul
Greg Simpkins
Nina Shea
Worship in Nigeria
28
August 2026
In-Person Event | Invite Only
Nigeria’s Crisis: Islamist Terrorists, Violent Nomadic Herders, “Bandit” Gangs, and the US Foreign Policy Response

Join Hudson Institute and the Ben Franklin Fellowship for a two-panel discussion examining US policy as it confronts the crisis of terror in Nigeria.

Worship in Nigeria
Featured Speakers:
Matthew Boyse
The Rev. Fr. Remigius Ihyula
Joshua Meservey
Ambassador Tibor Nagy
Emmanuel Ogebe
Judd Saul
Greg Simpkins
Nina Shea
09
September 2026
In-Person Event | Hudson Institute
Transferring Spectrum from the Federal to the Non-federal Domain: The View from NTIA
Featured Speakers:
Tricia J. Paoletta
Thomas Hazlett
J. Gregory Sikak
Harold Furchtgott-Roth
Tower
09
September 2026
In-Person Event | Hudson Institute
Transferring Spectrum from the Federal to the Non-federal Domain: The View from NTIA

Join Hudson Institute's Center for the Economics of the Internet for a keynote address  given by Tricia Paoletta on the Trump administration's progress in managing and reallocating the electromagnetic radio frequency spectrum from the federal domain.

Tower
Featured Speakers:
Tricia J. Paoletta
Thomas Hazlett
J. Gregory Sikak
Harold Furchtgott-Roth
14
September 2026
In-Person Event | Hudson Institute
Anticompetitive and Deceptive Conduct in Healthcare with FTC Chairman Andrew Ferguson
Featured Speakers:
Andrew Ferguson
Harold Furchtgott-Roth
Andrew Ferguson Headshot
14
September 2026
In-Person Event | Hudson Institute
Anticompetitive and Deceptive Conduct in Healthcare with FTC Chairman Andrew Ferguson

Join Hudson Institute for a discussion with Federal Trade Commission Chairman Andrew Ferguson and Senior Fellow Harold Furchtgott-Roth.

Andrew Ferguson Headshot
Featured Speakers:
Andrew Ferguson
Harold Furchtgott-Roth